80065071 - MACULA 2025

Saturday, January 11, 2025, 7:30 AM - 5:00 PM, Johns Hopkins University School of Medicine, Turner Bldg., Baltimore, MD


Over the past several years, there is a growing body of medical evidence demonstrating a clear biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of age related macular degeneration, diabetic retinopathy, and related diseases. Furthermore, there are new imaging and therapeutic approaches to vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina. These areas of investigation are relatively new, and most ophthalmologists are not aware of the myriad of new clinical trials relevant to these diseases. Thus, these subjects are areas of great interest both to ophthalmologists who treat these diseases and to those who refer these cases for further management. Presentations were chosen to emphasize new information and consensus on the use of these biologic agents to treat the neovascular and non-neovascular forms of age-related macular degeneration, vitreomacular interface abnormalities, diabetic retinopathy, intraocular tumors, and posterior uveitis. In addition, cases were chosen highlighting new information being reported by randomized clinical trials in these disease areas.

1. Explain the biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of age-related macular degeneration, diabetic retinopathy, and related diseases.
2. Discuss new imaging and therapeutic approaches to diabetic retinopathy, vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina.
3. Review the current and emerging therapeutic approaches for surgical retinal diseases.
4. Evaluate recent clinical studies evaluating treatments for retinal degenerations.

Canopy by Hilton Baltimore Harbor Point
1215 Wills Street
Baltimore, MD 21231
Phone: 443 960 8681
Fax: 443 960 8671
Hotel Rate: $189.00
Hotel Link: https://www.hilton.com/en/book/reservation/deeplink/?ctyhocn=BWIHPPY&groupCode=MAC&arrivaldate=2025-01-10&departuredate=2025-01-12&cid=OM,WW,HILTONLINK,EN,DirectLink&fromId=HILTONLINKDIRECT
Hotel Registration Cut Off Date: 12/12/2024 

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, January 11, 2025